货号:GS40797
Vofatamab (B-701) is an investigational fully human monoclonal antibody that specifically targets Fibroblast Growth Factor Receptor 3 (FGFR3). It is being developed primarily for the treatment of advanced urothelial carcinoma (bladder cancer), particularly in tumors with FGFR3 gene alterations, to inhibit tumor growth driven by aberrant FGFR3 signaling.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物